MINIMAL RESIDUAL DISEASE (MRD) ASSESSMENT AFTER ALLOGENEIC BMT FOR CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) ALLOWS EARLY PREDICTION OF RELAPSE

KNECHTLI C GOULDEN N HARRIS E HANCOCK J JONES C GRANDAGE V GARLAND R POTTER M CORNISH J PAMPHILON D STEWARD C OAKHILL A

C. Knechtli et al., MINIMAL RESIDUAL DISEASE (MRD) ASSESSMENT AFTER ALLOGENEIC BMT FOR CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) ALLOWS EARLY PREDICTION OF RELAPSE, Blood, 90(10), 1997, pp. 2431-2431

NO

Hematology

Blood → ACNP

00064971

90

10

1997

1

1

2431 - 2431

ISI

0006-4971(1997)90:10<2431:MRD(AA>2.0.ZU;2-2